daunorubicin has been researched along with Day Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A; Patnaik, MM; Viswanatha, DS | 1 |
| Frei, E; Lokich, JJ; Skarin, AT | 1 |
2 other study(ies) available for daunorubicin and Day Blindness
| Article | Year |
|---|---|
FLT3 Mutation Testing in Acute Myeloid Leukemia.
Topics: Cytarabine; Daunorubicin; fms-Like Tyrosine Kinase 3; Genetic Testing; Headache; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Leukostasis; Male; Middle Aged; Segmental Duplications, Genomic; Tandem Repeat Sequences; Vision Disorders | 2017 |
1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Cyclohexanes; Daunorubicin; Digestive System; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Heart; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Parotid Neoplasms; Stomatitis; Thrombocytopenia; Vision Disorders | 1974 |